Details

NameSymbolSector
VENUS REMEDIES LIMITEDVENUSREMPharmaceuticals
Open
0
High
480
Low
473.75
Close
473.75
Volume
1294
Exchange
nse
Time
14/08

Outlook

Score:  

2.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Venus Remedies is  
Normal
Estimated Stoploss of Venus Remedies is ₹  
473.75
Venus Remedies has a  
Bullishℹ
 pattern. 
Formation of  
Normal
 candle pattern indicates the trend direction of Venus Remedies is  
Unpredictableℹ
. 

Trend

Venus Remedies is in  
Strong Downtrendℹ
. 
Price of Venus Remedies is  
Downℹ
 by  

2.46

%. 
Target
Buy @ 

426

Sell @ 

519.4

Volume

The trade volumes of Venus Remedies have become  
Deficientℹ
The volume trend for Venus Remedies is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Venus Remedies is  

Down

 by  

98.04

% 

Valuation

The current market price of Venus Remedies is  
Undervaluedℹ

Financials

Balance
The balance sheet of Venus Remedies is:  

Balanced

Cashflow
Venus Remedies has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 8cr

. It is  
Downℹ
 by  

70.37

%. 

(*Mar 2025)

52.76% i.e. ₹ 86cr earned in operatingℹ
46.63% i.e. ₹ 76cr spent in investingℹ
0.61% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Venus Remedies has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 27cr

. It is  
Upℹ
 by  

222.73

%. 

(*Mar 2024)

80.43% i.e. ₹ 37cr earned in operatingℹ
15.22% i.e. ₹ 7cr spent in investingℹ
2.17% i.e. ₹ 1cr spent in financingℹ
2.17% i.e. ₹ 1cr spent in otherℹ
Income
The income of Venus Remedies is  

₹ 140cr

 and  

Profit

 is :  

₹ 9cr

(*Jun 2025)

Venus Remedies Profit is down by:  

57.14

% and Income is Down by:  

30.35

% 

(*Jun 2025)

The income of Venus Remedies is  

₹ 201cr

 and  

Profit

 is :  

₹ 21cr

(*Mar 2025)

Venus Remedies Profit is up by:  

10.53

% and Income is Up by:  

12.92

% 

(*Mar 2025)

The income of Venus Remedies is  

₹ 178cr

 and  

Profit

 is :  

₹ 19cr

(*Dec 2024)

Venus Remedies Profit is up by:  

533.33

% and Income is Up by:  

0

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.